From angiogenesis to lymphangiogenesis
- 1 February 2001
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (2), 151-152
- https://doi.org/10.1038/84579
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- VEGF-D promotes the metastatic spread of tumor cells via the lymphaticsNature Medicine, 2001
- Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasisNature Medicine, 2001
- Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3Nature Medicine, 2001
- VEGF Receptor Signaling in Tumor AngiogenesisThe Oncologist, 2000
- LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for HyaluronanThe Journal of cell biology, 1999
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Proceedings of the National Academy of Sciences, 1998
- Mechanisms of angiogenesisNature, 1997
- Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.Proceedings of the National Academy of Sciences, 1995
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989